199 related articles for article (PubMed ID: 27013387)
1. Effect of Serum Growth Differentiation Factor-15 and the Syntax Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Consuegra-Sanchez L
Am J Cardiol; 2016 May; 117(10):1569-1574. PubMed ID: 27013387
[TBL] [Abstract][Full Text] [Related]
2. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
[TBL] [Abstract][Full Text] [Related]
3. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
[TBL] [Abstract][Full Text] [Related]
4. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P
Am J Cardiol; 2011 Oct; 108(7):955-8. PubMed ID: 21784389
[TBL] [Abstract][Full Text] [Related]
5. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Serum Albumin Concentration to Predict High Coronary SYNTAX Score and In-Hospital Mortality in Patients With Acute Coronary Syndrome.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Koseoglu C; Celık IE; Kilic A; Aksoy O
Angiology; 2016 Jan; 67(1):34-40. PubMed ID: 25783433
[TBL] [Abstract][Full Text] [Related]
7. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognostic value of growth differentiation factor-15 in acute coronary syndromes.
Peiró ÓM; García-Osuna Á; Ordóñez-Llanos J; Cediel G; Bonet G; Rojas S; Quintern V; Bardají A
Clin Biochem; 2019 Nov; 73():62-69. PubMed ID: 31369736
[TBL] [Abstract][Full Text] [Related]
9. The association between growth differentiation factor 15 and presence and severity of coronary atherosclerosis.
Ozdemir E; Stavileci B; Ozdemir B; Aksoy FA; Kahraman S; Colakoglu Gevher CZ; Ziyrek M; Dogan A
Adv Med Sci; 2024 Mar; 69(1):56-60. PubMed ID: 38368744
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of the Clinical SYNTAX Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention.
He C; Song Y; Wang CS; Yao Y; Tang XF; Zhao XY; Gao RL; Yang YJ; Xu B; Yuan JQ
Am J Cardiol; 2017 May; 119(10):1493-1499. PubMed ID: 28341359
[TBL] [Abstract][Full Text] [Related]
12. The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery.
Redfors B; He CH; Palmerini T; Caixeta A; Giustino G; Ayele GM; Kirtane AJ; Mehran R; Stone GW; Généreux P
J Invasive Cardiol; 2017 Feb; 29(2):42-49. PubMed ID: 27974670
[TBL] [Abstract][Full Text] [Related]
13. Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.
Lindholm D; Hagström E; James SK; Becker RC; Cannon CP; Himmelmann A; Katus HA; Maurer G; López-Sendón JL; Steg PG; Storey RF; Siegbahn A; Wallentin L
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411246
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15 and geriatric conditions in acute coronary syndrome.
Sanchis J; Ruiz V; Bonanad C; Sastre C; Ruescas A; Díaz M; Rodríguez E; Valero E; García-Blas S; Carratalá A; Núñez E; Núñez J
Int J Cardiol; 2019 Sep; 290():15-20. PubMed ID: 31130280
[TBL] [Abstract][Full Text] [Related]
15. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Combining the Ankle-Brachial Index and SYNTAX Score for the Prediction of Outcome After Percutaneous Coronary Intervention (from the SHINANO Registry).
Ueki Y; Miura T; Miyashita Y; Motoki H; Shimada K; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Aso S; Uchikawa S; Hashizume N; Sekimura N; Morita T; Ebisawa S; Izawa A; Koyama J; Ikeda U
Am J Cardiol; 2016 Jan; 117(2):179-85. PubMed ID: 26684515
[TBL] [Abstract][Full Text] [Related]
17. Change in growth differentiation factor 15, but not C-reactive protein, independently predicts major cardiac events in patients with non-ST elevation acute coronary syndrome.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Hernandez-Baldomero IF; Avanzas P; Bosa-Ojeda F
Mediators Inflamm; 2014; 2014():929536. PubMed ID: 24839357
[TBL] [Abstract][Full Text] [Related]
18. The Mean Platelet Volume in the Prognosis of Coronary Artery Disease Severity and Risk Stratification of Acute Coronary Syndromes.
Vogiatzis I; Samaras A; Grigoriadis S; Sdogkos E; Koutsampasopoulos K; Bostanitis I
Med Arch; 2019 Apr; 73(2):76-80. PubMed ID: 31391691
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.
Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
PLoS One; 2018; 13(5):e0197609. PubMed ID: 29791474
[TBL] [Abstract][Full Text] [Related]
20. Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.
Kempf T; Sinning JM; Quint A; Bickel C; Sinning C; Wild PS; Schnabel R; Lubos E; Rupprecht HJ; Münzel T; Drexler H; Blankenberg S; Wollert KC
Circ Cardiovasc Genet; 2009 Jun; 2(3):286-92. PubMed ID: 20031597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
